Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression

Journal of Experimental Medicine

Volumn 186, Issue 9, 1997, Pages 1535-1546

  Giese, Nathalia A ^a   Gabriele, Lucia ^a   Doherty, T Mark ^a   Klinman, Dennis M ^c   Tadesse Heath, Lekidelu ^a   Contursi, Christina ^b   Epstein, Suzanne L ^c   Morse III, Herbert C ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c Center for Biologics Evaluation/Res   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERLEUKIN 12; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; HELPER CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; INFLUENZA VIRUS A; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL;

ANIMALS; CARRIER PROTEINS; CELL DIFFERENTIATION; CONSENSUS SEQUENCE; DISEASE SUSCEPTIBILITY; INFLUENZA A VIRUS; INTERFERON REGULATORY FACTORS; INTERFERONS; INTERLEUKIN-12; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORTHOMYXOVIRIDAE INFECTIONS; REPRESSOR PROTEINS; TH1 CELLS; TH2 CELLS; TRANSCRIPTION FACTORS;

EID: 0030670801     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.9.1535     Document Type: Article

References (74)

1. Darnell, J.E., Jr., I.M. Kerr, and G.R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science (Wash. DC). 264:1415-1421.
2. Taniguchi, T., H. Harada, and M. Lamphier, 1995. Regulation of the Interferon system and cell growth by the IRF transcription factors. J. Cancer Res. Clin. Oncol. 121:516-520.
3. Mittrucker, H.W., T. Matsuyama, A. Grossman, T.M. Kundig, J. Potter, A. Shahinian, A. Wakeham, B. Patterson, P.S. Ohashi, and T.W. Mak. 1997. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science (Wash. DC). 275:540-543.
4. Matsuyama, T., T. Kimura, M. Kitagawa, K. Pfeffer, T. Kawakami, N. Watanabe, T.M. Kundig, R. Amakawa, K. Kishihara. and A. Wakeham. 1993. Targeted disruption of IRF-I or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell. 75:83-97.
5. Kalvakolanu, D.V., and E.C. Borden. 1996. An overview of the interferon system: signal transduction and mechanisms of action. Cancer Invest. 14:25-53.
6. Nelson, N., Y. Kanno, C. Hong, C. Contursi, T. Fujita, B.J. Fowlkes, E. O'Connell, J. Hu-Li, W.E. Paul, D. Jankovic, et al. 1996. Expression of IFN regulatory factor family proteins in lymphocytes. Induction of Stat-1 and IFN consensus sequence binding protein expression by T cell activation. J. Immunol. 156:3711-3720.
7. Politis, A.D., K. Ozato, J.E. Coligan, and S.N. Vogel. 1994. Regulation of IFN-γ-induced nuclear expression of IFN consensus sequence binding protein in murine peritoneal macrophages. J. Immunol. 152:2270-2278.
8. Politis, A.D., J. Sivo, P.H. Driggers, K. Ozato, and S.N. Vogel. 1992. Modulation of interferon consensus sequence binding protein mRNA in murine peritoneal macrophages. Induction by IFN-γ and down-regulation by IFN-α, dexamethasone, and protein kinase inhibitors. J. Immunol. 148:801-807.
9. Sharf, R., D. Meraro, A. Azriel, A.M. Thornton, K. Ozato, E.F. Petricoin, A.C. Larner, F. Schaper, H. Hauser, and B.Z. Levi. 1997. Phosphorylation events modulate the ability of interferon consensus sequence binding protein to interact with interferon regulatory factors and to bind DNA. J. Biol. Chem. 272:9785-9792.
10. Bovolenta, C., P.H. Driggers, M.S. Marks, J.A. Medin, A.D. Politis, S.N. Vogel, D.E. Levy, K. Sakaguchi, E. Appella, J.E. Coligan, and K. Ozato. 1994. Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family. Proc. Natl. Acad. Sci. USA. 91:5046-5050.
11. Wang, I.M., J.C. Blanco, S.Y. Tsai, M.J. Tsai, and K. Ozato. 1996. Interferon regulatory factors and TFIIB cooperatively regulate interferon-responsive promoter activity in vivo and in vitro. Mol. Cell. Biol. 16:6313-6324.
12. Eisenbeis, C.F., H. Singh, and U. Storb. 1995. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev. 9:1377-1387.
13. Rutherford, M.N., A. Kumar, S.J. Haque, J. Ghysdael, and B.R. Williams. 1997. Specific binding of the ETS-domain protein to the interferon-stimulated response element. J. Interferon Cytokine: Res. 17:1-10.
14. Weisz, A., S. Kirchhoff, and B.Z. Levi. 1944. IFN consensus sequence binding protein (ICSBP) is a conditional repressor of IFN inducible promoters. Int. Immunol. 6:1125-131.
15. Nelson, N., M.S. Marks, P.M. Driggers, and K. Ozato. 1993. Interferon consensus sequence-binding protein, a member of the Interferon regulatory factor family, suppresses interferoninduced gene transcription. Mol. Cell. Biol. 13:588-599.
16. Weisz, A., P. Marx, R. Sharf, E. Appella, P.H. Driggers, K. Ozato, and B.Z. Levi. 1992. Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes. J. Biol. Chem. 267:25589-25596.
17. Thornton, A.M., V.V. Ogryzko, A. Dent, K. Shart, B.Z. Levi, Y. Kanno, L.M. Staudt, B.H. Howard, and K. Ozato. 1996. A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs. J. Immunol. 157:5145-5154.
18. Thornton, A.M., R.M. Buller, A.L. DeVico, I.M. Wang, and K. Ozato. 1996. Inhibition of human immunodeficiency virus type 1 and vaccinia virus infection by a dominant negative factor of the interferon regulatory factor family expressed in monocytic cells. Proc. Natl. Acad. Sci. USA. 93:383-387.
19. Bovolenta, C., J. Lou, Y. Kanno, B.K. Park, A.M. Thornton, J.E. Coligan, M. Schubert, and K. Ozato. 1995. Vesicular stomatitis virus infection induces a nuclear DNA-binding factor specific for the interferon-stimulated response element. J. Virol. 69:4173-4181.
20. Fehr, T., G. Schoedon, B. Odermatt, T. Holtschke, M. Schneemann, M.F. Bachmann, T.W. Mak, I. Horak, and R.M. Zinkernagel. 1997. Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listerosis. J. Exp. Med. 185:921-931.
21. Holtschke, T., J. Löhler, Y. Kanno, T. Fehr, N. Giese, F. Rosenbauer, J. Lou, K.P. Knobeloch, L. Gabriele, J.F. Waring et al. 1996. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell. 87:307-317.
22. Athens, J.W., and J.H. Ward. 1993. Complications of hematopoietic neoplasm. In Wintrobe's Clinical Hematology. G.R. Lee, T.C. Bithell, J. Foerster, J.W. Athens, and J.N. Lukens, editors. Lea & Febiger, Philadelphia. 1792-1842.
23. Athens, J.W. 1993. Chronic myeloid leukemia. In Wintrobe's Clinical Hematology. G.K. Lee, T.C. Bithell, J. Foerster, J.W. Athens, and J.N. Lukens, editors. Lea & Febiger, Philadelphia. 1969-1998.
24. Akiyama, H., T. Maruyama, T. Uetake, K. Kawaguchi, H. Sakamaki, and Y. Onozawa. 1991. Systemic infection due to atypical Mycobacteria in patients with chronic myelogenous leukemia. Rev. Infect. Dis. 13:815-818.
25. Doherty, T.M., and R.L. Coffman. 1996. Leishmania major: effect of infectious dose on T cell subset development in BALB/c mice. Exp. Parasitol. 84:124-135.
26. Klinman, D.M., A.K. Yi, S.L. Beaucage, J. Conover, and A.M. Krieg. 1996. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ. Proc. Natl. Acad. Sci. USA. 93:2879-2883.
27. Krieg, A.M., A.K. Yi, S. Matson, T.J. Waldschmidt, G.A. Bishop, R. Teasdale, G.A. Koretzky, and D.M. Klinman. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature (Lond.). 374:546-549.
28. Le Gros, G., S.Z. Ben-Sasson, R. Seder, F.D. Finkelman, and W.E. Paul. 1990. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J. Exp. Med. 172: 971-929.
29. Svetic, A., F.D. Finkelman, Y.C. Jian, C.W. Dieffenbach, D.E. Scott, K.F. McCarthy, A.D. Steinberg, and W.C. Gause. 1991. Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J. Immunol. 147:2391-2397.
30. Giese, N.A., R.T. Gazzinelli, J.K. Actor, R.A. Morawetz, M. Sarzotti, and H.C. Morse, III. 1996. Retrovirus-elicited interleukin-12 and tumour necrosis factor-α as inducers of interferon-γ-mediated pathology in mouse AIDS, Immunology. 87:467-474.
31. Gazzmelli, R.T., I. Eltoum, T.A. Wynn, and A. Sher. 1993. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-α and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J. Immunol. 151:3672-3681.
32. Olson, M.C., E.W. Scott, A.A. Hack, G.H. Su, D.G. Tenen, H. Singh, and M.C. Simon. 1995. PU.1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation. Immunity. 3:703-714.
33. Carrera L., R.T. Gazzinelli, R. Badolato, S. Hieny, W. Müller, R. Kühn, and D.L. Sacks. 1996. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J. Exp. Med. 183:515-526.
34. Shirai, A., K. Holmes, and D. Klinman. 1993. Detection and quantitation of cells secreting IL-6 under physiologic conditions in BALB/c mice J. Immnnol. 150:793-799.
35. Franzoso, G., L. Carlson, T. Scharton-Kersten, E. W. Shores, S. Epstein, A. Grinberg, T. Tran, E. Shacter, A. Leonardi, M. Anver, et al. 1997. Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic imcroarchitecture, and germinal center reactions. Immunity. 6:479-490.
36. Sacks, D.L., S. Hieny, and A. Sher. 1985. Identification of cell surface carbohydrate and antigenic changes between non-infective and infective developmental stages of Leishmania major promastigotes. J. Immunol. 135:564-569.
37. Titus, R.G., M. Marchand, T. Boon, and J.A. Louis, 1985. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol. (Oxf.). 7:545-555.
38. Snapper, C.M., and W.E. Paul. 1987. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science (Wash. DC). 236:944-947.
39. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251-276.
40. Scott, P. 1993. IL-12: initiation cytokine for cell-mediated immunity. Science (Wash. DC). 260:496-497.
41. Trinchieri, G. 1997. Cycokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-γ). Curr. Opin. Immunol. 9:17-23.
42. Roman, L., A. Mencacci, E. Cenci, R. Spaccapelo, G. Del Sero, I. Nicoletti, G. Trinchieri, F. Bistoni, and P. Puccetti. 1997. Neutrophil production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice. J. Immunol. 158:5349-5356.
43. Takenaka, H., S. Maruo, N. Yamamoto, M. Wysocka, S. Ono, M. Kobayashi, H. Yagita, K. Okumura, T. Hamaoka, G. Trinchieri, and H. Fujiwara. 1997. Regulation of T cell-dependent and -independent IL-12 production by the three Th2-type cytokines IL-10, IL-6, and IL-4. J. Leukocyte Biol. 61:80-87.
44. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells trigger production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747-752.
45. Kelsall, B.L., E. Stuber, M. Neurath, and W. Strober. 1996. Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses. Ann. NY Acad. Sci.. 795:116-126.
46. Heufler, C., F. Koch, U. Stanzl, G. Topar, M. Wysocka, G. Trinchieri, A. Enk, R.M. Steinman, N. Romani, and G. Schuler. 1996. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-γ production by T helper 1 cells. Eur. J. Immunol. 26:659-668.
47. Rutherford, M.S., A. Witsell, and L.B. Schook. 1993. Mechanisms generating functionally heterogeneous macrophages: chaos revisited. J. Leukocyte Biol. 53:602-618.
48. Chehimi, J., C. Paganin, I. Frank, S. Chouaib, S. Starr, and G. Trinchieri. 1995. Interleukin-12 in the pathogenesis and therapy of HIV disease. Res. Immunol. 146:605-614.
49. Stuber, E., W. Strober, and M. Neurath. 1996. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J. Exp. Med. 183:693-698.
50. Campbell, K.A., P.J. Ovendale, M.K. Kennedy, W.C. Fanslow, S.G. Reed, and C.R. Maliszewski. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity. 4:283-289.
51. Kato, T., R. Hakamada, H. Yamane, and H. Nariuchi. 1996. Induction of IL-12 p40 messenger RNA expression and IL-12 production of macrophages via CD40-CD40 ligand interaction. J. Immunol. 156:3932-3938.
52. Kennedy, M.K., K.S. Picha, W.C. Fanslow, K.H. Grabstein, M.R. Alderson, K.N. Clifford, W.A. Chin, and K.M. Mohler. 1996. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur. J. Immunol. 26:370-378.
53. Lohoff, M., D. Ferrick, H.-W. Mittrucker, G.S. Duncan, S. Bischof, M. Rollinghoff, and T.W. Mak. 1997. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity. 6:681-689.
54. Taki, S., T. Sato, K. Ogasawara, T. Fukuda, M. Sato, S. Hida, G. Suzuki, M. Mitsuyama, E.-H. Shin, S. Kojima, et al. 1997. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity. 6:673-679.
55. Salkowski, C.A., S.A. Barber, G.R. Detore, and S.N. Vogel. 1996. Differential dysregulation of nitric oxide production in macrophages with targeted disruptions in IFN regulatory factor-1 and -2 genes, J. Immunol. 156:3107-3110.
56. Ma, X., J.M. Chow, G. Gri, G. Carra, F. Gerosa, S.F. Wolf, R. Dzialo, and G. Trinchieri. 1996. The interleukin 12 p40 gene promoter is primed by interferon γ in monocytic cells. J. Exp. Med. 183:147-157.
57. Ma, X., M. Neurath, G. Gri, and G. Trinchieri. 1997. Identification and characterization of a novel Ets-2-related nuclear complex implicated in the activation of the human interleukin-12 p40 gene promoter. J. Biol. Chem. 272:10389-10395.
58. Murphy, T.L., M.G. Cleveland, P. Kulesza, J. Magram, and K.M. Murphy. 1995. Regulation of interleukin 12 p40 expression through an NF-κH half-site. Mol. Cell. Biol. 15: 5258-5267.
59. Cousens, L.P., J.S. Orange, H.C. Su, and C.A. Biron. 1997. Interferon-α/β inhibition of interleukin 12 and interferon-γ production in vitro and endogenously during viral infection. Proc. Natl. Acad. Sci. USA. 94:634-639.
60. 2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol. 159:28-35.
61. Scharton-Kersten, T., L.C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott. 1995. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154:5320-5330.
62. + T cells during initiation of infection. J. Exp. Med. 179:447-456.
63. Heinzel, F.P., R.M. Rerko, F. Ahmed, and E. Pearlman. 1995. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J. Immunol. 155:730-793.
64. Sartori, A., P. Scott, and G. Trinchieri. 1996. Leishmania major metacyclogenesis modulates ability to induce IL-12. Ann. NY Acad. Sci. 795:400-402.
65. Guler, M.L., J.D. Gorham, C.S. Hsieh, A.J. Mackey, R.G. Steen, W.F. Dietrich, and K.M. Murphy. 1996. Genetic susceptibility to Leishmania: IL-12 responsiveness in Th1 cell development. Science (Wash. DC). 271:984-987.
66. Bogdan, C., A. Gessner, W. Solbach, and M. Rollinghoff. 1996. Invasion, control and persistence of Leishmania parasites. Curr. Opin. Immunol. 8:517-525.
67. Laskay, T., A. Diefenbach, M. Rollinghoff, and W. Solbach. 1995. Early parasite containment is decisive tor resistance to Leishmania major infection. Eur. J. Immunol. 25:2220-2227.
68. Ridley, D.S. 1987. Pathology. III. Cutaneous leishmaniasis. In The Leishmaniases in Biology and Medicine. W. Peters and R. Killick-Kendrick, editors. Academic Press, London. 665-701.
69. Doherty, T.M., and R.L. Coffman. 1993. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major. J. Immmunol. 150:5476-5483.
70. McDowell, M.A., D.M. Lucas, C.M. Nicolet, and D.M. Paulnock. 1995. Differential utilization of IFN-γ-responsive elements in two maturationally distinct macrophage cell lines. J. Immunol. 155:4933-4938.
71. Nicolet, C.M., and D.M. Paulnock. 1994. Promoter analysis of an interferon-inducible gene associated with macrophage activation. J. Immunol. 152:153-162.
72. Narumi, S., and T.A. Hamilton. 1991. Inducible expression of murine IP-10 mRNA varies with the state of macrophage inflammatory activity. J. Immunol. 146:3038-3044.
73. Ohmori, Y., and T.A. Hamilton. 1995. The interferon-stimulated response element and a κB site mediate synergistic induction of murine IP-10 gene transcription by IFN-γ and TNF-α. J. Immunol. 154:5235-5244.
74. Tsitsikov, E.N., N. Ramesh, and R.S. Geha. 1994. Structure of the murine CD40 ligand gene. Mol. Immunol. 31:895-900.